CA 15-3 and Related Mucins as Circulating Markers in Breast Cancer

This publication has 35 references indexed in Scilit:

• Summary Report on the ISOBM TD-4 Workshop: Analysis of 56 Monoclonal Antibodies against the MUC1 Mucin
  Tumor Biology, 1998
• Value of CA 15.3 in breast cancer and comparison with CEA and TPA: A study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the first metastasis
  Breast Cancer Research and Treatment, 1996
• A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.
  Molecular Biology of the Cell, 1996
• Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference values
  American Journal of Obstetrics and Gynecology, 1996
• Epithelial Mucin Genes
  Annual Review of Physiology, 1995
• Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease
  European Journal Of Cancer, 1994
• Cell membrane-associated mucins and their adhesion-modulating property
  Trends in Biochemical Sciences, 1992
• Assessment of four monoclonal antibodies as serum markers in breast cancer
  European Journal of Cancer and Clinical Oncology, 1990
• Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer
  European Journal of Cancer and Clinical Oncology, 1989
• Monoclonal antibodies against human milk‐fat globule membranes detecting differentiation antigens of the mammary gland and its tumors
  International Journal of Cancer, 1984